← Every company
Dexcom Inc Planned Sales
Before an insider at Dexcom Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
DXCM insider trades →Notices on file
4
Insiders
3
Shares noticed
12.4K
permission to sell, not sales
Estimated value
$1M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Nicholas AugustinosDirector2026-09-156.5K sh<0.01% | $549.5K |
| Stern SadieOfficer2026-09-282.6K sh<0.01% | $221K |
| Brown MichaelOfficer2026-09-151.7K sh<0.01% | $142.9K |
| Nicholas AugustinosDirector2026-09-141.6K sh<0.01% | $130.2K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on DXCM
Company overviewEverything on DXCM in one place, with the price.SEC filingsWhat DXCM's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat DXCM's own officers and directors buy and sell.Who owns itEvery manager reporting a position in DXCM.Funds holding itWhich funds and ETFs hold DXCM, and how big a bet.LobbyingWhat DXCM spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on DXCM's account, and who they worked for.PatentsWhat DXCM is filing at the patent office.